health
FDA considering doctor-like assessment for AI-enabled devices
Emerging technologies are presenting novel regulatory challenges.
TL;DR
- The FDA is exploring a competency-based approach to evaluate generative AI-enabled medical devices.
- This approach is inspired by how human clinicians are assessed and credentialed.
- The agency aims to create a nimble regulatory framework that balances patient safety with timely access to innovative devices.
- Generative AI devices present unique regulatory challenges due to their variable outputs and continuous evolution.
- The FDA is considering benchmarks and clinical performance confirmation for premarket evaluation.
- Postmarket monitoring strategies are also being weighed, potentially accepting greater premarket uncertainty.
- The discussion paper seeks to inform the development of a global model for regulating AI medical technologies.